ProShares Ultra Nasdaq Biotechnology (BIB)
NASDAQ: BIB · Real-Time Price · USD
80.59
-0.45 (-0.56%)
Apr 7, 2026, 4:00 PM EDT - Market closed
BIB Holdings Information
BIB is an equity ETF with a total of 265 individual holdings.
Total Holdings
265
Top 10 Percentage
151.70%
Asset Class
Equity
ETF Category
Trading--Leveraged Equity
Assets
81.00M
PE Ratio
n/a
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | n/a | NASDAQ BIO INDEX SWAP BNP PARIBAS | 35.65% |
| 2 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA | 31.09% |
| 3 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA | 26.87% |
| 4 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL | 19.16% |
| 5 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE | 14.45% |
| 6 | GILD | Gilead Sciences, Inc. | 5.40% |
| 7 | AMGN | Amgen Inc. | 5.06% |
| 8 | VRTX | Vertex Pharmaceuticals Incorporated | 5.01% |
| 9 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG | 4.59% |
| 10 | REGN | Regeneron Pharmaceuticals, Inc. | 4.42% |
| 11 | ALNY | Alnylam Pharmaceuticals, Inc. | 2.44% |
| 12 | INSM | Insmed Incorporated | 1.97% |
| 13 | BIIB | Biogen Inc. | 1.41% |
| 14 | UTHR | United Therapeutics Corporation | 1.37% |
| 15 | ARGX | argenx SE | 1.18% |
| 16 | RPRX | Royalty Pharma plc | 1.13% |
| 17 | ROIV | Roivant Sciences Ltd. | 1.11% |
| 18 | ILMN | Illumina, Inc. | 1.09% |
| 19 | MRNA | Moderna, Inc. | 1.07% |
| 20 | RVMD | Revolution Medicines, Inc. | 1.05% |
| 21 | INCY | Incyte Corporation | 1.05% |
| 22 | VTRS | Viatris Inc. | 0.86% |
| 23 | SMMT | Summit Therapeutics Inc. | 0.81% |
| 24 | MEDP | Medpace Holdings, Inc. | 0.78% |
| 25 | BBIO | BridgeBio Pharma, Inc. | 0.78% |
As of Apr 6, 2026